CFSMX
Price
$13.68
Change
+$0.13 (+0.96%)
Updated
Oct 3 closing price
Net Assets
904.12M
MVCAX
Price
$32.44
Change
+$0.22 (+0.68%)
Updated
Oct 3 closing price
Net Assets
17.13B
Interact to see
Advertisement

CFSMX vs MVCAX

Header iconCFSMX vs MVCAX Comparison
Open Charts CFSMX vs MVCAXBanner chart's image
Clarkston Partners Founders
Price$13.68
Change+$0.13 (+0.96%)
VolumeN/A
Net Assets904.12M
MFS Mid Cap Value A
Price$32.44
Change+$0.22 (+0.68%)
VolumeN/A
Net Assets17.13B
CFSMX vs MVCAX Comparison Chart in %
View a ticker or compare two or three
VS
CFSMX vs. MVCAX commentary
Oct 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CFSMX is a Buy and MVCAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 17.1B vs. CFSMX (904M). MVCAX pays higher dividends than CFSMX: MVCAX (0.84) vs CFSMX (0.54). CFSMX was incepted earlier than MVCAX: CFSMX (10 years) vs MVCAX (24 years). MVCAX (1.00) is less costly to investors than CFSMX (0.88). MVCAX is a more actively managed with annual turnover of: 27.00 vs. CFSMX (22.00). MVCAX has a lower initial minimum investment than CFSMX: MVCAX (1000) vs CFSMX (100000000). MVCAX annual gain was more profitable for investors over the last year : -4.63 vs. CFSMX (-5.65). MVCAX return over 5 years is better than : 53.86 vs. CFSMX (9.14).
CFSMXMVCAXCFSMX / MVCAX
Total Expense Ratio0.850.9986%
Annual Report Gross Expense Ratio0.881.0088%
Fund Existence10 years24 years-
Gain YTD-6.6805.737-116%
Front LoadN/A6%-
Min. Initial Investment100000000100010,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets904M17.1B5%
Annual Yield % from dividends0.540.8464%
Returns for 1 year-5.65-4.63122%
Returns for 3 years-10.2720.78-49%
Returns for 5 years9.1453.8617%
Returns for 10 years44.0278.4856%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACTU6.980.29
+4.33%
Actuate Therapeutics Inc
ARQQ49.921.33
+2.74%
Arqit Quantum Inc
FE45.930.47
+1.03%
FirstEnergy Corp
TLX10.280.06
+0.59%
Telix Pharmaceuticals Ltd.
KRKR7.280.01
+0.14%
36KR Holdings Inc